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Summary Objective: To determine the effectiveness of implementing clinical prac-
tice guidelines (CPG) on antibiotic prescribing for adults with upper respiratory in-
fection (URI) in terms of the changes in diagnosis and prevalence and patterns of
antibiotic prescribing.
Methods: The CPG on antibiotic treatments for adults with URI published in the
Annals of Internal Medicine 2001; 134: 479—52 were considered to be of high quality
and applicable to Thai patients. A one-page clinical practice protocol in Thai was
prepared from these guidelines. The dissemination strategy provided CPG and clini-
cal practice protocol to 12 general practitioners in Siriraj Social Security Program in
Bangkok during interactive educational meetings in April 2001. The information on
837 URI episodes from January to March (pre-CPG phase) and 774 URI episodes dur-
ing May to July (post-CPG phase) were extracted from the patients’ medical records.
Telephone follow up for patients without antibiotics in the post-CPG phase was also
attempted.
Results: Changes in the post-CPG period included (1) The diagnosis of URI was used
less frequently whereas the diagnosis of common cold, pharyngitis and acute bronchi-
tis were used more frequently (p < 0.05). (2) Antibiotic use fell from 74.0% to 44.1%
(p < 0.001). (3) Fewer prescriptions for amoxicillin, roxithromycin, co-trimoxazole
and doxycycline, and more for penicillin V (p < 0.05). Patients (n = 97) not given
antibiotics reported recovery in 83.5% and improvement in 16.5%.
Conclusion: A locally prepared clinical practice protocol based on US CPG for ap-
propriate antibiotic use for URI combined with interactive educational meetings is
effective in promoting appropriate diagnosis and antibiotic therapy in an ambulatory
setting in a tertiary care hospital in Thailand.
© 2003 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
*Corresponding author. Tel.: +66-24-12-5994;
fax: +66-24-12-5994.
E-mail address: sivth@mahidol.ac.th (V. Thamlikitkul).
Introduction
The prevalence of penicillin-resistant Streptococ-
cus pneumoniae in Thailand increased to 42% in
2000.1,2 Overuse of antibiotics for minor respiratory
infections is found to be an important factor for the
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selection of resistant strains.3—6 Antibiotics are pre-
scribed to 51—76% of adults with upper respiratory
infections (URI) in the United States.7,8 We found
that antibiotics were prescribed to 80% of adults
with URI who visited the Social Security Program at
Siriraj Hospital, Bangkok, Thailand in the year 2000.
It seems reasonable that reducing the use of unnec-
essary antibiotics could decrease or at least halt the
development of drug-resistant streptococci.9—11 Ef-
fective interventions are needed in view of the high
rates of antibiotic resistance and use in Thailand
and other countries.
The objective of this study was to determine the
effectiveness of a simple one-page clinical prac-
tice protocol and US CPG for appropriate antibiotic
use for URI combined with interactive educational
meetings with general practitioners to improve the
diagnosis and the use of antibiotics for adults with
URI.
Clinical Practice Protocol on Antibiotic Use in Adults with Upper Respiratory 
Infections (URI) * 
 
This protocol is intended for guiding general practitioners in making diagnoses and
prescribing antibiotics for adults with upper respiratory infections in ambulatory care.  
 
An adult who has no chronic or serious underlying diseases and presents to 
ambulatory care with symptoms and/or signs of upper respiratory infections should 
receive a more specific diagnosis of ‘common cold’ or ‘rhinitis’ or ‘rhinopharyngitis’ or 
‘pharyngitis’ or ‘tonsillitis’ or ‘sinusitis’ or ‘acute bronchitis’ depending on his/her major 
symptoms and signs.  
A diagnosis of ‘URI’ should be avoided. 
 
The recommended treatments for each clinical syndrome of upper respiratory 
infections are: 
 
Common cold/rhinitis/non-specific upper respiratory tract infections 
• Symptomatic therapy such as an antipyretic should be given 
• An antibiotic is not necessary since this syndrome is almost always caused 
by viruses.  
 
Pharyngitis/tonsillitis 
• Symptomatic therapy such as an antipyretic should be given 
• An antibiotic should not be given routinely since most of the cases are caused  
by viruses. An antibiotic should be given to the patient who has at least three 
of the following criteria: fever, tonsillar exudate, tender anterior cervical  
lymphadenopathy, no cough. The antibiotic of first choice is penicillin V since
group A streptococcus  has not been resistant to penicillin. Erythromycin should
replace penicillin V for the patient allergic to penicillin. 
 
Sinusitis/rhinosinusitis 
• The patient with mild symptoms should receive symptomatic therapy such as 
an antipyretic. An antibiotic may not be given 
• The patient with severe symptoms or persistent symptoms longer than seven 
days should receive an antibiotic. The antibiotic of first choice is amoxicillin. 
 
Acute bronchitis 
• The patient should receive symptomatic treatment such as an antipyretic 
• A β-agonist inhaler may relieve the symptoms  
• An antibiotic is not necessary since this syndrome is usually caused by viruses.  
 
* This protocol is modified from Principles of Appropriate Antibiotic Use for Treatment 
of Acute Respiratory Tract Infections in Adults: Background, Specific Aims, and 
Methods. Annals of Internal Medicine 2001;134 :479–529  
Figure 1 Translation into English from Thai of the Clinical Practice Protocol.
Methods
The study was approved and endorsed by Faculty of
Medicine Siriraj Hospital, Mahidol University. It was
conducted at Siriraj Hospital in Bangkok, a 2000-bed
tertiary care university hospital. There are about
80,000 adult outpatient visits annually to the So-
cial Security Program in the hospital clinic. URI ac-
counts for about 5% of these visits. The key recom-
mendations presented in position papers on appro-
priate antibiotic use for URI in adults (Ann Intern
Med 2001; 134: 479-529) were used to prepare a
one-page clinical practice protocol in the Thai lan-
guage (Figure 1).
The ﬁrst part of the protocol emphasizes an im-
portance for the diagnosis of speciﬁc clinical syn-
dromes, i.e., common cold, rhinitis, non-speciﬁc
upper respiratory tract infections, pharyngitis, ton-
sillitis, sinusitis, rhinosinusitis and acute bronchitis.
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The second part focuses on the antibiotics recom-
mended for each clinical syndrome. The clinical
practice protocol and US CPG were presented to 12
general practitioners who provided care for the So-
cial Security Program. Two sessions of interactive
educational meeting were organized in April 2001.
Each session lasted 1.5 hours.
One of the investigators (VT) presented the cur-
rent situation on antibiotic use for adults with URI at
the ambulatory care service of Social Security Pro-
gram and the necessity for change. The rationale
for a separate diagnosis of each clinical URI syn-
drome and the principles for prescribing antibiotics
for each clinical syndrome were then explained. Ev-
idence for each recommendation in the CPG was
clariﬁed. The physicians agreed to adhere to the
clinical practice protocol.
Sample size was based on the following consid-
erations. The antibiotic prescription rate for adults
with URI at the ambulatory care service of Social
Security Program at Siriraj Hospital in 2000 was
approximately 80%. It was hypothesized that an-
tibiotic prescriptions could be reduced to 50% or
less. For a 5% type I error and 20% type II error, 50
episodes of URI for each general practitioner were
required. Therefore at least 600 episodes of URI for
each period were needed. The medical records of
the patients who attended ambulatory care service
from January to March 2001 (pre-CPG period) and
May to July 2001 (post-CPG period) were retrieved.
The inclusion criteria were that:
• The adult patients had no underlying diseases and
that they received care from the participating
general practitioners.
• Information was extracted on diagnoses and an-
tibiotic prescriptions.
• The clinical outcomes for patients who received
no antibiotics during the post-CPG period were
assessed by telephone interviews at seven days
following their visits.
• The data were analyzed by descriptive statistics.
All comparisons were performed by a chi-square
Table 1 Clinical syndromes of URI made by general practitioners.




p Relative risk (95%
conﬁdence interval)
URI 720 (86.0%) 242 (31.1%) <0.001 0.36 (0.33-0.40)
Pharyngitis 49 (5.9%) 192 (24.8%) <0.001 4.24 (3.2-5.7)
Bronchitis 38 (4.5%) 99 (12.8%) <0.001 2.6 (1.8-3.7)
Tonsillitis 24 (2.9%) 17 (2.2%) 0.5 0.8 (0.4-1.4)
Common cold 5 (0.6%) 223 (28.8%) <0.001 48 (20-116)
Sinusitis 1 (0.1%) 1 (0.1%) 1
test using Epi-Info version 6. All statistical
tests were 2-sided and considered signiﬁcant at
p < 0.05.
Results
The URI clinical syndromes identiﬁed by general
practitioners during the two study periods are
shown in Table 1. The diagnosis of URI was signiﬁ-
cantly reduced and pharyngitis, the common cold
and bronchitis were diagnosed more often during
the post-CPG period compared to the pre-CPG pe-
riod. Time series analysis of clinical syndromes of
URI revealed no signiﬁcant difference among the
months during each period. The antibiotic pre-
scription rates were 74.0% in the pre-CPG period
and 44.1% in the post-CPG period (p < 0.001, RR
0.6 with 95% CI 0.55—0.65).
The antibiotics prescribed during each period are
shown in Table 2. There was a signiﬁcant reduction
in use of amoxicillin, co-trimoxazole, roxithromycin
and doxycycline; and penicillin V was prescribed
signiﬁcantly more often during the post-CPG period
compared with the pre-CPG period. Time series
analysis of antibiotic prescription rates revealed
no signiﬁcant difference among the months during
each period. Co-trimoxazole is not recommended
in the URI antibiotic guidelines, nevertheless it
accounted for 22.3% of the patients’ prescriptions
during the pre-CPG period and 17.1% during the
post-CPG period. The correlation between the clin-
ical syndromes of URI and antibiotic prescribing is
shown in Table 3. The antibiotic prescription rate
for the common cold was signiﬁcantly less than for
all other clinical syndromes of URI for both periods.
The antibiotic prescription rates for URI, bronchitis
and the common cold were signiﬁcantly less during
the post-CPG period when compared with those
during the pre-CPG period.
Telephone interviews at seven days post-visit
were attempted for 192 patients who received no
antibiotics during the post-CPG period. Of these
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Amoxicillin 289 (34.5%) 108 (14%) <0.001 0.45 (0.37-0.55)
Cotrimoxazole 187 (22.3%) 132 (17.1%) 0.01 0.76 (0.62-0.93)
Roxithromycin 79 (9.4%) 22 (3%) <0.001 0.3 (0.19-0.48)
Doxycycline 21 (2.5%) 4 (0.5%) 0.01 0.21 (0.07-0.6)
Penicillin V 16 (1.9%) 72 (9.3%) <0.001 4.87 (2.86-8.29)
Cefuroxime 11 (1.3%) 0
Erythromycin 3 (0.4%) 2 (0.3%)
Spiramycin 6 (0.7%) 0
Co-amoxiclav* 1 (0.1%) 0
Lincomycin 3 (0.4%) 1 (0.1%)
Cephalexin 2 (0.2%) 0
Norﬂoxacin 1 (0.1%) 0
* Amoxicillin-clavulanate.
Table 3 Prevalence of antibiotic prescribing in each
clinical syndrome of URI.










Common cold* 20 10
* p < 0.01 when compared with other clinical
syndromes.
97 (50.5%) were contacted after two attempts.
Eighty-one (83.5%) of patients reported URI re-
covery, 16 (16.5%) reported that they had much
improved.
Discussion
Clinical practice guidelines are tools for changing
clinicians’ behaviour. Success in promoting more
appropriate healthcare behaviour in clinicians de-
pends on the quality and relevance of clinical prac-
tice guidelines and the effectiveness of the strat-
egy used to disseminate the information. It was
found that the URI CPG published in the Annals of
Internal Medicine to be of a high quality according
to Shaneyfelt’s criteria12 and relevant to clinical
practice in Thailand. They are however in English
and are much too long and detailed to be useful
for busy practitioners. It was felt that only a few
key points were needed to construct a practical
protocol. Two main issues were focused upon: diag-
nosis and antibiotic prescribing for healthy adults
with URI. It was elected to use interactive educa-
tional meetings for this study because it has been
demonstrated to be an effective dissemination
strategy.13,14
The intervention used in the study was effective
in changing clinicians’ behaviour in the diagnosis
and treatment of URI patients. Similar results have
been obtained by different interventions.15,16 It is
believed that amajor factor contributing to the suc-
cess of the current intervention was the substantial
increase in the diagnosis of the common cold. Most
of the clinic physicians agreed that antibiotics are
not needed for this condition. A relatively small pro-
portion of the patients were diagnosed with pharyn-
gitis or tonsillitis, but antibiotic prescription rates
for these two syndromes were still high (78—94%).
This appears to be excessive since only up to 30%
of the healthy adults with pharyngo-tonsillitis were
found to have a positive throat culture for Strepto-
coccus pyogenes (Thamlikitkul V, unpublished data).
Use of rapid diagnostic methods for this bacterium
should help reduce rate of antibiotic use, but may
not reduce costs.
Co-trimoxazole is not recommended in the URI
antibiotic guidelines. Nevertheless it accounted
for 22.3% of the patients’ prescriptions during the
pre-CPG period and 17.1% during the post-CPG
period. This is explained by the use of this drug
by one senior clinician for almost all his patients
with URI. He did not change his prescribing be-
haviour after receiving the intervention. When
this practitioner’s practice was excluded, the
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antibiotic prescription rates were reduced from
66.8% to 34.2% for the pre-CPG period and post-CPG
period respectively (p < 0.001). He has now
retired.
Several issues continue to be of concern. First,
although the antibiotic prescription rates fell from
74.0% to 44.1%, they still remained high in the
post-CPG period. Ideally the antibiotic prescrip-
tion rate for healthy adults with URI should not
exceed 10%, since more than 90% are not caused by
bacteria. Given the uncertainty of clinical ﬁndings
in differentiating bacterial from viral infection in
pharyngitis and tonsillitis, the antibiotic prescrip-
tion rate would be expected to exceed 10% for these
conditions, but a 44.1% use during the post-CPG pe-
riod still appears to be excessive. Second, although
the selection of antibiotics during the post-CPG
period tended to be more appropriate, the choice
made by the general practitioners needs to be im-
proved. Third, this intervention was successful for
at least a three-month period. In order to maintain
the effectiveness of our intervention, all general
practitioners have been reminded every six months
since January 2002. The prevalence of antibiotic
prescribing in 100 consecutive adult patients with
URI in June 2002 was 41%. Finally, evidence-based
clinical practice guidelines may need to be shown
to be safe as well as effective under ﬁeld condi-
tions. It was found that virtually all patients who
did not receive antibiotics during the post-CPG pe-
riod had improved and none required readmission.
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